Oligodendrocytes In Cns Myelination is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Oligodendrocytes are the myelin-forming cells of the central nervous system (CNS), responsible for ensheathing neuronal axons with the multilayered myelin sheath that enables rapid saltatory conduction of action potentials. A single oligodendrocyte can myelinate up to 60 different axons simultaneously, making them uniquely efficient among glial cells. Dysfunction of oligodendrocytes is central to demyelinating diseases including multiple sclerosis (MS) and the rare but fatal leukodystrophies.
| Property |
Value |
| Category |
Glial cells |
| Location |
Throughout CNS (brain and spinal cord) |
| Cell Type |
Myelin-forming oligodendrocyte |
| Origin |
Oligodendrocyte precursor cells (OPCs) |
| Function |
Myelin formation, axonal support, saltatory conduction |
¶ Development and Lineage
Oligodendrocytes develop from oligodendrocyte precursor cells (OPCs), which arise from distinct embryonic origins:
- Motor neuron progenitor domain (pMN): Primary source in spinal cord
- Medial ganglionic eminence (MGE): Contributes to forebrain oligodendrocytes
- Cortical subventricular zone: Secondary source
- OPC Proliferation: OPCs divide and migrate throughout the CNS
- Pre-oligodendrocyte: Early differentiation marker (O4)
- Immature Oligodendrocyte: Myelin basic protein (MBP) expression
- Mature Oligodendrocyte: Full myelin gene expression, myelination
¶ Cell Body
- Relatively small soma (5-10 μm)
- Multiple branching processes
- Located in white matter tracts and gray matter
- Multi-layered lipid membrane
- Internode: Main myelinated region (200-2000 μm)
- Node of Ranvier: Unmyelinated gap (1 μm)
- Paranode: Border region
- Juxtaparanode: Adjacent to paranode
Myelin is approximately 70% lipid and 30% protein:
- PLP (Proteolipid Protein): Most abundant protein (50%)
- MBP (Myelin Basic Protein): Structural integrity (30%)
- CNP (2',3'-Cyclic Nucleotide 3'-Phosphodiesterase): Cytoskeletal link
- MAG (Myelin-Associated Glycoprotein): Axonal adhesion
- Cholesterol
- Phospholipids (phosphatidylcholine, phosphatidylethanolamine)
- Galactocerebroside
- Sulfatides
The primary function of oligodendrocytes is to form the myelin sheath:
- Myelin creates electrical insulation around axons
- Action potentials "jump" between nodes of Ranvier
- Conduction velocity increases 10-100x
- Reduces ionic currents at nodes
- Decreases ATP consumption
- Essential for long-range neural communication
Oligodendrocytes provide critical metabolic support to axons:
- Oligodendrocytes transfer lactate to axons
- Supports axonal energy demands
- Essential for axonal survival
- Produce neurotrophic factors (BDNF, GDNF)
- Maintain axonal cytoskeleton
- Prevent axonal degeneration
¶ Myelin Maintenance
Mature oligodendrocytes maintain myelin integrity:
- Continuous turnover of myelin components
- Response to minor axonal damage
- Remyelination capacity (limited in humans)
MS is the most common demyelinating disease:
Pathology:
- Focal demyelinated lesions in CNS
- Inflammatory infiltrates (T-cells, B-cells, microglia)
- Axonal loss
- Progressive disability
Oligodendrocyte Involvement:
- Primary target of autoimmune attack
- Failure of remyelination (shadow plaques)
- Oligodendrocyte precursor dysfunction
Therapeutic Targets:
- Immune modulation ( natalizumab, ocrelizumab)
- Remyelination promotion (clemastine, opicinumab)
- Neuroprotection
Genetic disorders affecting white matter:
- ARSA deficiency
- Sulfatide accumulation
- Progressive demyelination
- GALC deficiency
- Psychosine accumulation
- Early-onset severe demyelination
¶ Alexander Disease
- GFAP mutations
- Rosenthal fiber formation
- White matter degeneration
- ASPA deficiency
- N-acetylaspartate accumulation
- Spongiform degeneration
- Oligodendrocyte dysfunction contributes to motor neuron loss
- Impaired glutamate metabolism
- Reduced lactate support
- Therapeutic target potential
- White matter abnormalities in AD
- Oligodendrocyte vulnerability to amyloid
- Myelin breakdown precedes neuronal loss
- Contributes to cognitive decline
¶ Stroke and Ischemia
- Oligodendrocytes highly vulnerable to ischemia
- White matter damage in stroke
- Contributes to motor and cognitive deficits
Remyelination is the process of regenerating myelin sheaths:
- OPCs proliferate in response to demyelination
- OPCs differentiate into new oligodendrocytes
- New myelin sheaths form on denuded axons
- Efficient in young individuals
- Declines with age
- FAILS in progressive MS
- Promoting OPC recruitment
- Enhancing differentiation
- Overcoming inhibitory environment
Oligodendrocytes exhibit significant diversity:
- Cortical vs. subcortical oligodendrocytes
- White matter vs. gray matter (intracortical)
- Region-specific myelin thickness
- Normal aging leads to myelin breakdown
- Accumulation of myelin fragments
- Reduced remyelination capacity
Common oligodendrocyte markers:
- MBP (Myelin Basic Protein)
- PLP (Proteolipid Protein)
- Olig2 (Oligodendrocyte transcription factor 2)
- CC1 (Adenomatous polyposis coli)
- NG2 (Neuron-glial antigen 2) - OPC marker
- Disease-modifying therapies: Modulate immune response
- Symptomatic treatments: Manage specific symptoms
- Remyelination drugs: Clemastine, opicinumab
- Stem cell therapy: OPC transplantation
- Gene therapy: For leukodystrophies
- Neuroprotection: Prevent axonal loss
The study of Oligodendrocytes In Cns Myelination has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Baumann & Pham-Dinh, Biology of oligodendrocytes (2001) - Physiological Reviews
- Nave & Trapp, Axon-glial signaling (2008) - Annual Review of Neuroscience
- Franklin & Ffrench-Constant, Remyelination in the CNS (2008) - Nature Reviews Neuroscience
- Simons & Nave, Oligodendrocytes (2015) - Neuron
- Miron & Franklin, Stem cells and remyelination (2014) - Brain
- Pffeifer et al., Oligodendrocyte heterogeneity (2004) - Nature Neuroscience
- Rivers et al., Adult OPCs and remyelination (2008) - Cell Stem Cell
- Fancy et al., Regulating OPC differentiation (2009) - Nature Reviews Neuroscience